Stock futures are slipping after China’s third-quarter economic growth came in below economists’ forecasts. Here’s what we’re watching ahead of Monday’s opening bell.
dropped 6.1% premarket. The online real-estate company told Bloomberg that it won’t purchase homes for the rest of the year, saying that it was “beyond operational capacity.”
are due to report earnings before the open.
rose more than 2% premarket after Silver Lake said it was acquiring ICE’s 9.85% stake in Euroclear Holding.
- Crude prices were climbing early Monday, boosting the share prices of producers.
gained 2.3% and
- Bitcoin was trading above $61,000, and digital-wallet provider
was up 1.3% before the bell.
- U.S.-traded shares of French biotech
soared 39% premarket. It said its coronavirus vaccine candidate outperformed
‘s in a Phase 3 study, which met both its co-primary endpoints.
Johnson & Johnson,
meanwhile, edged up 0.2% after a panel of outside doctors and experts voted 19-0 to recommend that all adults who received a first dose of the Johnson & Johnson vaccine should get the second dose at least two months later.
- Vaccine maker
was down 0.8% premarket. Last week the FDA delayed a decision on making its Covid-19 shot available for adolescents, to assess whether it may lead to heightened risk of a rare inflammatory heart condition.
will report earnings after the close.
Chart of the Day
- Hong Kong started trading in futures tied to an index of stocks from mainland China, giving global investors a new tool for betting on Chinese markets.
Write to James Willhite at firstname.lastname@example.org
Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8